Esophageal Cancer
Also known as: Cancer of Esophagus / Oesophageal Cancer / Malignant Neoplasm of Esophagus / Oesophageal neoplasms malignant / Esophageal Cancers / Esophageal Neoplasms Malignant / Esophageal Cancers NOS / Oesophagus Cancer / Cancer Esophagus / Esophagus Cancer / Oesophageal cancer NOS / Esophageal cancer NOS / Ca oesophagus NOS / Ca esophagus NOS (disorder) / Ca esophagus / Malignant neoplasm of esophagus, unspecified / Malignant neoplasm of oesophagus, unspecified / Malignant tumour of oesophagus / Ca oesophagus / Malignant neoplasm of esophagus NOS (disorder) / (Malignant neoplasm of oesophagus NOS or oesophageal cancer / Malignant tumor of esophagus (disorder) / Primary malignant neoplasm of esophagus (disorder) / Malignant neoplasm of oesophagus / Carcinoma of esophagus (disorder) / Malignant neoplasm of esophagus NOS / Malignant neoplasm of oesophagus NOS / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Carcinoma of esophagus / Oesophageal carcinoma NOS / Oesophageal carcinoma / Esophageal carcinoma NOS / Esophageal carcinoma
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
| DB00762 | Irinotecan | An antineoplastic enzyme inhibitor used to treat metastatic carcinoma of the colon or rectum. |
| DB01229 | Paclitaxel | A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer. |
| DB00707 | Porfimer sodium | A hematoporphyrin derivative used to treat esophageal cancer, endobronchial cancer, and high grade dysplasia in Barrett's Esophagus. |